Surface Oncology Inc (NASDAQ:SURF)

Delayed Data
As of Oct 04
 +0.11 / +10.09%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Surface Oncology Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 8.50. The median estimate represents a +900.00% increase from the last price of 1.20.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Surface Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.72%
Growthannually 29.38%


Growthquarterly --
Growthannually 1,114.49%
Key to the earnings and sales forecast charts.